跳至主要内容
临床试验/ACTRN12616000003471
ACTRN12616000003471已完成未知

Will an adapted Mediterranean diet (BC-MED) improve health in breast cancer survivors?

The University of Auckland0 个研究点目标入组 45 人开始时间: 2016年1月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
Female

入选标准

  • Those aged 50 or above, diagnosed with grade 1-3 breast cancer and three or more months following active treatment and a body mass index (BMI) >25 will be enrolled. Participants can be on hormonal therapy. Participants will need to provide medical information regarding their breast cancer grade. We request participants provide receptor expression and use of hormone therapy, but those who wish to keep this information private will still be eligible.

排除标准

  • We will exclude those on anti-inflammatory medication; those who drink more than 2 standard alcoholic beverages per day; those diagnosed with diabetes mellitus or those who smoke tobacco.

研究者

相似试验